The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Agreement between FGFR2 immunohistochemistry assays and fluorescence in situ hybridization (FISH) in metastatic gastric cancer: A comparison study.
 
Grigory A. Raskin
Research Funding - R-Pharm
 
Marina S. Mukhina
No Relationships to Disclose
 
Elena D. Kravtsova
No Relationships to Disclose
 
Sergei Tjulandin
Stock and Other Ownership Interests - RosPharmTech
Consulting or Advisory Role - AstraZeneca; BioCad; Lilly; Novartis; Roche
Speakers' Bureau - AstraZeneca; Merck Sharp & Dohme; Novartis; Pierre Fabre; R-Pharm; Roche
Research Funding - Abbvie (Inst); Bristol Myers Squibb Foundation (Inst); Eisai (Inst); Merck (Inst); Novartis (Inst); SERVIER
 
Ilya Tsimafeyeu
Leadership - Ruspharmtech
Stock and Other Ownership Interests - Ruspharmtech
Honoraria - Bristol-Myers Squibb/Celgene; Novartis; Pfizer
Consulting or Advisory Role - Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Novartis; Pfizer; Ruspharmtech
Research Funding - Novartis (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Kidney Cancer Research Bureau; Oncomax LLC; Ruspharmtech